Nature Biotechnology, volume 38, issue 11, pages 1242-1252

COVID-19 antibodies on trial

Laura Defrancesco 1
Publication typeJournal Article
Publication date2020-10-21
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor46.9
ISSN10870156, 15461696
Molecular Medicine
Applied Microbiology and Biotechnology
Biotechnology
Bioengineering
Biomedical Engineering
Abstract
With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products.

Top-30

Citations by journals

1
2
3
4
5
Scientific Reports
5 publications, 5.21%
Frontiers in Immunology
3 publications, 3.13%
Antiviral Research
3 publications, 3.13%
Viruses
2 publications, 2.08%
Nature
2 publications, 2.08%
Vaccine
2 publications, 2.08%
Nature Communications
2 publications, 2.08%
Current Molecular Medicine
1 publication, 1.04%
Pharmacological Reports
1 publication, 1.04%
Cells
1 publication, 1.04%
Molecules
1 publication, 1.04%
Vaccines
1 publication, 1.04%
Life
1 publication, 1.04%
International Journal of Molecular Sciences
1 publication, 1.04%
Frontiers in Molecular Biosciences
1 publication, 1.04%
Frontiers in Pharmacology
1 publication, 1.04%
Pharmaceutical Medicine
1 publication, 1.04%
Microbial Cell Factories
1 publication, 1.04%
Cell and Bioscience
1 publication, 1.04%
Journal of Microbiology
1 publication, 1.04%
Current Transplantation Reports
1 publication, 1.04%
Molecular Biology Reports
1 publication, 1.04%
Pharmaceutical Research
1 publication, 1.04%
Nature Medicine
1 publication, 1.04%
Cell Chemical Biology
1 publication, 1.04%
Virologica Sinica
1 publication, 1.04%
Acta Pharmaceutica Sinica B
1 publication, 1.04%
BioScience Trends
1 publication, 1.04%
BMC Health Services Research
1 publication, 1.04%
1
2
3
4
5

Citations by publishers

2
4
6
8
10
12
14
16
18
Springer Nature
18 publications, 18.75%
Cold Spring Harbor Laboratory
17 publications, 17.71%
Elsevier
12 publications, 12.5%
Wiley
8 publications, 8.33%
Multidisciplinary Digital Publishing Institute (MDPI)
7 publications, 7.29%
Frontiers Media S.A.
6 publications, 6.25%
Taylor & Francis
4 publications, 4.17%
Bentham Science
2 publications, 2.08%
American Chemical Society (ACS)
2 publications, 2.08%
Oxford University Press
2 publications, 2.08%
American Association for the Advancement of Science (AAAS)
2 publications, 2.08%
Han-Gug Misaengmul Hag-hoe/The Microbiological Society of Korea
1 publication, 1.04%
KeAi Communications Co.
1 publication, 1.04%
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)
1 publication, 1.04%
American Society for Biochemistry and Molecular Biology
1 publication, 1.04%
Royal Society of Chemistry (RSC)
1 publication, 1.04%
American Society for Microbiology
1 publication, 1.04%
EMBO press
1 publication, 1.04%
Korea Genome Organization
1 publication, 1.04%
Heighten Science Publications Corporation
1 publication, 1.04%
Higher Education Press
1 publication, 1.04%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.04%
2
4
6
8
10
12
14
16
18
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Defrancesco L. COVID-19 antibodies on trial // Nature Biotechnology. 2020. Vol. 38. No. 11. pp. 1242-1252.
GOST all authors (up to 50) Copy
Defrancesco L. COVID-19 antibodies on trial // Nature Biotechnology. 2020. Vol. 38. No. 11. pp. 1242-1252.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41587-020-0732-8
UR - https://doi.org/10.1038/s41587-020-0732-8
TI - COVID-19 antibodies on trial
T2 - Nature Biotechnology
AU - Defrancesco, Laura
PY - 2020
DA - 2020/10/21 00:00:00
PB - Springer Nature
SP - 1242-1252
IS - 11
VL - 38
SN - 1087-0156
SN - 1546-1696
ER -
BibTex |
Cite this
BibTex Copy
@article{2020_Defrancesco,
author = {Laura Defrancesco},
title = {COVID-19 antibodies on trial},
journal = {Nature Biotechnology},
year = {2020},
volume = {38},
publisher = {Springer Nature},
month = {oct},
url = {https://doi.org/10.1038/s41587-020-0732-8},
number = {11},
pages = {1242--1252},
doi = {10.1038/s41587-020-0732-8}
}
MLA
Cite this
MLA Copy
Defrancesco, Laura. “COVID-19 antibodies on trial.” Nature Biotechnology, vol. 38, no. 11, Oct. 2020, pp. 1242-1252. https://doi.org/10.1038/s41587-020-0732-8.
Found error?